A NIDA-funded study at the University of Pennsylvania Transdisciplinary Tobacco Use Research Center has found that the anti-depressant bupropion may help people stop smoking by alleviating negative moods, such as depression
and despair, often experienced during nicotine withdrawal. This is the first study to find that such psychological changes may contribute to bupropion's effects on smoking cessation outcomes in a clinical setting.
Dr. Caryn Lerman of the Abramson Cancer Center of the University of Pennsylvania led the research team that examined 251 male and female smokers ages 18 and older. Participants were randomly assigned to receive 10 weeks
of treatment with bupropion or a placebo, plus behavioral counseling. Bupropion was initiated on the day of the first counseling session, two weeks before the target quit date. Counseling included nicotine fading (slowly decreasing
nicotine intake), coping with cues that trigger smoking, stress management, and relapse prevention. During treatment, participants regularly completed questionnaires about their withdrawal symptoms and positive and negative feelings.
At the end of treatment, 48 percent of bupropion participants were abstinent from smoking, versus 29 percent of those receiving the placebo. The bupropion group exhibited a decrease in negative mood, while those receiving
placebo showed an increase in negative mood. Although bupropion reduced the severity of the symptoms of withdrawal, negative mood was more strongly related to smoking relapse.
WHAT IT MEANS: Bupropion may be beneficial for smokers who experience negative moods and who smoke, in part, to manage these symptoms.
#
'"/>
Contact: Blair Gately
Bgately@nida.nih.gov
301-443-6245
NIH/National Institute on Drug Abuse
4-Nov-2002
Page: 1 Related medicine news :1.
Anti-depressants used during pregnancy linked to neonatal withdrawal syndrome2.
Study finds bupropion may be effective smoking cessation aid for women3.
Immersion in virtual world alleviates pain from injury4.
Kadian alleviated chronic pain in patients unsuccessfully treated with well-known therapies5.
Climara Pro (TM) helps alleviate menopausal hot flashes and night sweats6.
Mayo Clinic study shows melatonin helps alleviate violent sleep disorder symptoms7.
Yale researchers create topical estrogen that alleviates sexual dysfunction in menopausal women and eliminates side effects of conventional estrogen8.
Antidepressant drug alleviates hot flashes in men undergoing prostate cancer treatment9.
Anger, negative emotions may trigger stroke10.
Re-analysis of large trials shows greatest benefit of chemotherapy in ER-negative tumors11.
Acute decrease in testosterone level has few negative effects on healthy men